Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

ROS1-rearranged Non-small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS).

Chiari R, Ricciuti B, Landi L, Morelli AM, Delmonte A, Spitaleri G, Cortinovis DL, Lamberti G, Facchinetti F, Pilotto S, Verusio C, Chella A, Bonanno L, Galetta D, Cappuzzo F.

Clin Lung Cancer. 2019 Jun 18. pii: S1525-7304(19)30154-8. doi: 10.1016/j.cllc.2019.06.012. [Epub ahead of print]

PMID:
31607443
2.

New High-Quality Draft Genome of the Brown Rot Fungal Pathogen Monilinia fructicola.

De Miccolis Angelini RM, Romanazzi G, Pollastro S, Rotolo C, Faretra F, Landi L.

Genome Biol Evol. 2019 Oct 1;11(10):2850-2855. doi: 10.1093/gbe/evz207.

PMID:
31560373
3.

Crizotinib in MET deregulated or ROS1 rearranged pretreated non-small-cell lung cancer (METROS): a phase II, prospective, multicentre, two-arms trial.

Landi L, Chiari R, Tiseo M, D'Incà F, Dazzi C, Chella A, Delmonte A, Bonanno L, Giannarelli D, Cortinovis DL, De Marinis F, Borra G, Morabito A, Gridelli C, Galetta D, Barbieri F, Grossi F, Capelletto E, Minuti G, Mazzoni F, Verusio C, Bria E, Alì G, Bruno R, Proietti A, Fontanini G, Crinò L, Cappuzzo F.

Clin Cancer Res. 2019 Aug 15. pii: clincanres.0994.2019. doi: 10.1158/1078-0432.CCR-19-0994. [Epub ahead of print]

PMID:
31416808
4.

Perioperative dental screening and treatment in patients undergoing cardio-thoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology.

Cotti E, Cairo F, Bassareo PP, Fonzar F, Venturi M, Landi L, Parolari A, Franco V, Fabiani C, Barili F, Di Lenarda A, Gulizia M, Borzi M, Campus G, Musumeci F, Mercuro G.

Int J Cardiol. 2019 Oct 1;292:78-86. doi: 10.1016/j.ijcard.2019.06.041. Epub 2019 Jun 17.

PMID:
31262607
5.

Perioperative dental screening and treatment in patients undergoing cardio-thoracic surgery and interventional cardiovascular procedures. A consensus report based on RAND/UCLA methodology.

Cotti E, Cairo F, Bassareo PP, Fonzar F, Venturi M, Landi L, Parolari A, Franco V, Fabiani C, Barili F, Di Lenarda A, Gulizia M, Borzi M, Campus G, Musumeci F, Mercuro G.

Int Endod J. 2019 Jun 4. doi: 10.1111/iej.13166. [Epub ahead of print]

PMID:
31162683
6.

Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Oldest Adults: Predictors of In-Hospital Mortality and Need for Post-acute Care.

Spannella F, Giulietti F, Cocci G, Landi L, Lombardi FE, Borioni E, Cenci A, Giordano P, Sarzani R.

J Am Med Dir Assoc. 2019 Jul;20(7):893-898. doi: 10.1016/j.jamda.2019.01.125. Epub 2019 Feb 28.

PMID:
30826270
7.

Detection of 'Candidatus Phytoplasma solani' in roots from Bois noir symptomatic and recovered grapevines.

Landi L, Murolo S, Romanazzi G.

Sci Rep. 2019 Feb 14;9(1):2013. doi: 10.1038/s41598-018-38135-9.

8.

Programmed death ligand 1 expression in early stage, resectable non-small cell lung cancer.

D'Arcangelo M, D'Incecco A, Ligorio C, Damiani S, Puccetti M, Bravaccini S, Terracciano L, Bennati C, Minuti G, Vecchiarelli S, Landi L, Milesi M, Meroni A, Ravaioli S, Tumedei MM, Incarbone M, Cappuzzo F.

Oncotarget. 2019 Jan 15;10(5):561-572. doi: 10.18632/oncotarget.26529. eCollection 2019 Jan 15.

9.

Intraoperative Treatment of Duct of Luschka during Laparoscopic Cholecystectomy: A Case Report and Revision of Literature.

Masoni L, Landi L, Maglio R.

Case Rep Surg. 2018 Dec 17;2018:9813489. doi: 10.1155/2018/9813489. eCollection 2018.

10.

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.

Passaro A, Prelaj A, Bonanno L, Tiseo M, Tuzi A, Proto C, Chiari R, Rocco D, Genova C, Sini C, Cortinovis D, Pilotto S, Landi L, Bennati C, Camerini A, Toschi L, Putzu C, Cerea G, Spitaleri G, Cappuzzo F, de Marinis F.

Clin Lung Cancer. 2019 Mar;20(2):e186-e194. doi: 10.1016/j.cllc.2018.11.005. Epub 2018 Nov 20.

PMID:
30563752
11.

Genome sequence of the brown rot fungal pathogen Monilinia fructigena.

Landi L, De Miccolis Angelini RM, Pollastro S, Abate D, Faretra F, Romanazzi G.

BMC Res Notes. 2018 Oct 23;11(1):758. doi: 10.1186/s13104-018-3854-z.

12.

Cetuximab in the treatment of advanced non-small cell lung cancer: FISHing for a miraculous catch.

Landi L, Rossi A.

J Thorac Dis. 2018 Jun;10(Suppl 17):S1940-S1944. doi: 10.21037/jtd.2018.04.126. No abstract available.

13.

Does the Bursa Pre-Macularis protect the fovea from shear stress? A possible mechanical role.

Rossi T, Badas MG, Querzoli G, Trillo C, Telani S, Landi L, Gattegna R, Ripandelli G.

Exp Eye Res. 2018 Oct;175:159-165. doi: 10.1016/j.exer.2018.06.022. Epub 2018 Jun 21.

PMID:
29935948
14.

Including cannabinoids in the treatment of painful schwannomatosis.

Iorno V, Roberto A, Colantonio LB, Landi L, Corli O.

Brain Behav. 2018 Jul;8(7):e01011. doi: 10.1002/brb3.1011. Epub 2018 May 29. No abstract available.

15.

Tooth Loss and Dental Implant Outcomes-Where is dentistry going? A Survey by SIdP, the Italian Society of Periodontology and Implantology.

Cairo F, Landi L, Gatti C, Rasperini G, Aimetti M; SIdP, the Italian Society of Periodontology and Implantology.

Oral Dis. 2018 Oct;24(7):1379-1381. doi: 10.1111/odi.12898. Epub 2018 Jun 11. No abstract available.

16.

Circulating programmed death ligand-1 (cPD-L1) in non-small-cell lung cancer (NSCLC).

Vecchiarelli S, Passiglia F, D'Incecco A, Gallo M, De Luca A, Rossi E, D'Incà F, Minuti G, Landi L, Bennati C, Spreafico M, D'Arcangelo M, Mazza V, Normanno N, Cappuzzo F.

Oncotarget. 2018 Apr 3;9(25):17554-17563. doi: 10.18632/oncotarget.24785. eCollection 2018 Apr 3.

17.

Combination Therapy of Inhaled Indacaterol/Glycopyrronium for Chronic Obstructive Pulmonary Disease in the Very Elderly: Is It Safe? An Electrocardiographic Evaluation.

Spannella F, Giulietti F, Cesari V, Francioso A, Cocci G, Landi L, Lombardi FE, Borioni E, Bernardi B, Rosettani G, Bordoni V, Iacoacci C, Giordano P, Sarzani R.

Respiration. 2018;95 Suppl 1:22-29. doi: 10.1159/000487182. Epub 2018 Apr 27.

18.

N-terminal pro B-Type natriuretic peptide is inversely correlated with low density lipoprotein cholesterol in the very elderly.

Spannella F, Giulietti F, Cocci G, Landi L, Borioni E, Lombardi FE, Rosettani G, Bernardi B, Bordoni V, Giordano P, Bordicchia M, Sarzani R.

Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):629-635. doi: 10.1016/j.numecd.2018.02.013. Epub 2018 Feb 27.

PMID:
29650297
19.

Bladder management during pregnancy in women with spinal-cord injury: an observational, multicenter study.

Andretta E, Landi LM, Cianfrocca M, Manassero A, Risi O, Artuso G.

Int Urogynecol J. 2019 Feb;30(2):293-300. doi: 10.1007/s00192-018-3620-8. Epub 2018 Mar 29.

PMID:
29600402
20.

HER2 Deregulation in Lung Cancer: Right Time to Adopt an Orphan?

Cappuzzo F, Landi L.

Clin Cancer Res. 2018 Jun 1;24(11):2470-2472. doi: 10.1158/1078-0432.CCR-18-0198. Epub 2018 Mar 1.

21.

Renin-Angiotensin System Blockers and Statins Are Associated With Lower In-Hospital Mortality in Very Elderly Hypertensives.

Spannella F, Giulietti F, Balietti P, Cocci G, Landi L, Lombardi FE, Borioni E, Bernardi B, Rosettani G, Bordoni V, Sarzani R.

J Am Med Dir Assoc. 2018 Apr;19(4):342-347. doi: 10.1016/j.jamda.2017.09.023. Epub 2017 Nov 8.

PMID:
29128438
22.

A few pills twice a day keep ALK-positive non-small-cell lung cancer at bay.

Landi L, Cappuzzo F.

J Thorac Dis. 2017 Aug;9(8):2311-2314. doi: 10.21037/jtd.2017.07.76. No abstract available.

23.

Ocular perfusion pressure control during pars plana vitrectomy: testing a novel device.

Rossi T, Querzoli G, Gelso A, Angelini G, Rossi A, Corazza P, Landi L, Telani S, Ripandelli G.

Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2325-2330. doi: 10.1007/s00417-017-3799-2. Epub 2017 Sep 8.

PMID:
28887584
24.

Plasma renin activity to plasma aldosterone concentration ratio correlates with night-time and pulse pressures in essential hypertensive patients treated with angiotensin-converting enzyme inhibitors/AT1 blockers.

Spannella F, Giulietti F, Balietti P, Borioni E, Lombardi FE, Ricci M, Cocci G, Landi L, Sarzani R.

J Hypertens. 2017 Nov;35(11):2315-2322. doi: 10.1097/HJH.0000000000001438.

PMID:
28614094
25.

Proximal hypospadias repair with bladder mucosal graft: Our 10 years experience.

Lanciotti M, Betti M, Elia A, Landi L, Taverna M, Cini C, Masieri L.

J Pediatr Urol. 2017 Jun;13(3):294.e1-294.e6. doi: 10.1016/j.jpurol.2017.01.011. Epub 2017 Feb 17.

PMID:
28341425
26.

Global Transcriptome Analysis and Identification of Differentially Expressed Genes in Strawberry after Preharvest Application of Benzothiadiazole and Chitosan.

Landi L, De Miccolis Angelini RM, Pollastro S, Feliziani E, Faretra F, Romanazzi G.

Front Plant Sci. 2017 Feb 24;8:235. doi: 10.3389/fpls.2017.00235. eCollection 2017.

27.

The effectiveness of a nursing discharge programme to improve medication adherence and patient satisfaction in the psychiatric intensive care unit.

Virgolesi M, Pucciarelli G, Colantoni AM, D'Andrea F, Di Donato B, Giorgi F, Landi L, Salustri E, Turci C, Proietti MG.

J Clin Nurs. 2017 Dec;26(23-24):4456-4466. doi: 10.1111/jocn.13776. Epub 2017 May 3.

PMID:
28233457
28.

Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC.

Landi L, Cappuzzo F.

Transl Lung Cancer Res. 2016 Dec;5(6):579-587. doi: 10.21037/tlcr.2016.12.05. Review.

29.

The neuropilin 2 isoform NRP2b uniquely supports TGFβ-mediated progression in lung cancer.

Gemmill RM, Nasarre P, Nair-Menon J, Cappuzzo F, Landi L, D'Incecco A, Uramoto H, Yoshida T, Haura EB, Armeson K, Drabkin HA.

Sci Signal. 2017 Jan 17;10(462). pii: eaag0528. doi: 10.1126/scisignal.aag0528.

30.

Interarm blood pressure differences predict target organ damage in type 2 diabetes.

Spannella F, Giulietti F, Fedecostante M, Ricci M, Balietti P, Cocci G, Landi L, Bonfigli AR, Boemi M, Espinosa E, Sarzani R.

J Clin Hypertens (Greenwich). 2017 May;19(5):472-478. doi: 10.1111/jch.12963. Epub 2016 Dec 27.

31.

Perioprosthetic and Implant-Supported Rehabilitation of Complex Cases: Clinical Management and Timing Strategy.

Landi L, Piccinelli S, Raia R, Marinotti F, Manicone PF.

Case Rep Dent. 2016;2016:2634093. Epub 2016 Nov 7.

32.

RE: Long-term efficacy of microbiology-driven periodontal laser-assisted therapy, by Martelli et al., Eur J Clin Microbiol Infect Dis 2016, 35(3): 423-431.

Gatti C, Aimetti M, Rasperini G, Landi L, Cairo F; SIdP, Italian Society of Periodontology and Implantology.

Eur J Clin Microbiol Infect Dis. 2017 Feb;36(2):395-397. doi: 10.1007/s10096-016-2785-7. Epub 2016 Oct 13. No abstract available.

33.

Overcoming resistance to first/second generation epidermal growth factor receptor tyrosine kinase inhibitors and ALK inhibitors in oncogene-addicted advanced non-small cell lung cancer.

Romanidou O, Landi L, Cappuzzo F, Califano R.

Ther Adv Med Oncol. 2016 May;8(3):176-87. doi: 10.1177/1758834016631531. Epub 2016 Feb 16. Review.

34.

Management of NSCLC Disease Progression After First-Line EGFR Tyrosine Kinase Inhibitors: What Are the Issues and Potential Therapies?

Califano R, Romanidou O, Mountzios G, Landi L, Cappuzzo F, Blackhall F.

Drugs. 2016 May;76(8):831-40. doi: 10.1007/s40265-016-0578-z. Review.

PMID:
27129321
35.

Assessing the toxicity of sediments using the medaka embryo-larval assay and 2 other bioassays.

Barhoumi B, Clérandeau C, Landi L, Pichon A, Le Bihanic F, Poirier D, Anschutz P, Budzinski H, Driss MR, Cachot J.

Environ Toxicol Chem. 2016 Sep;35(9):2270-80. doi: 10.1002/etc.3388. Epub 2016 Jun 15.

PMID:
26823140
36.

microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.

Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, Alì G, D'Incecco A, Minuti G, Chella A, Fontanini G, Fassan M, Cappuzzo F, Croce CM.

Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14924-9. doi: 10.1073/pnas.1520329112. Epub 2015 Nov 16.

37.

Ceritinib for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer.

Landi L, Cappuzzo F.

Expert Rev Clin Pharmacol. 2016;9(2):203-14. doi: 10.1586/17512433.2016.1122518. Epub 2015 Dec 16. Review.

PMID:
26582431
38.

Genetic Variability of Stolbur Phytoplasma in Hyalesthes obsoletus (Hemiptera: Cixiidae) and its Main Host Plants in Vineyard Agroecosystems.

Landi L, Riolo P, Murolo S, Romanazzi G, Nardi S, Isidoro N.

J Econ Entomol. 2015 Aug;108(4):1506-15. doi: 10.1093/jee/tov103. Epub 2015 May 7.

PMID:
26470289
39.

MET deregulation in breast cancer.

Minuti G, Landi L.

Ann Transl Med. 2015 Aug;3(13):181. doi: 10.3978/j.issn.2305-5839.2015.06.22. Review.

40.

Preharvest treatments with chitosan and other alternatives to conventional fungicides to control postharvest decay of strawberry.

Feliziani E, Landi L, Romanazzi G.

Carbohydr Polym. 2015 Nov 5;132:111-7. doi: 10.1016/j.carbpol.2015.05.078. Epub 2015 Jun 8.

PMID:
26256331
41.

Experience with erlotinib in the treatment of non-small cell lung cancer.

Landi L, Cappuzzo F.

Ther Adv Respir Dis. 2015 Aug;9(4):146-63. doi: 10.1177/1753465815588053. Epub 2015 Jun 10. Review.

PMID:
26063687
42.

Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study.

D'Arcangelo M, Todaro M, Salvini J, Benfante A, Colorito ML, D'Incecco A, Landi L, Apuzzo T, Rossi E, Sani S, Stassi G, Cappuzzo F.

PLoS One. 2015 May 8;10(5):e0125037. doi: 10.1371/journal.pone.0125037. eCollection 2015.

43.

Recommendations on complementary feeding for healthy, full-term infants.

Alvisi P, Brusa S, Alboresi S, Amarri S, Bottau P, Cavagni G, Corradini B, Landi L, Loroni L, Marani M, Osti IM, Povesi-Dascola C, Caffarelli C, Valeriani L, Agostoni C.

Ital J Pediatr. 2015 Apr 28;41:36. doi: 10.1186/s13052-015-0143-5. Review.

44.

Platform switching vs standard implants in partially edentulous patients using the Dental Tech Implant System: clinical and radiological results from a prospective multicenter study.

Del Fabbro M, Bianchessi C, Del Lupo R, Landi L, Taschieri S, Corbella S.

Clin Oral Investig. 2015 Dec;19(9):2233-44. doi: 10.1007/s00784-015-1462-z. Epub 2015 Mar 31.

PMID:
25820990
45.

Writing in PROSE proteomic-based selection for second line treatment in non-small-cell lung cancer.

Landi L, Cappuzzo F.

Ann Transl Med. 2015 Mar;3(3):32. doi: 10.3978/j.issn.2305-5839.2015.02.12. No abstract available.

46.

Targeting MET in NSCLC: looking for a needle in a haystack.

Landi L, Cappuzzo F.

Transl Lung Cancer Res. 2014 Dec;3(6):389-91. doi: 10.3978/j.issn.2218-6751.2014.11.05. No abstract available.

47.

Prolapsed vaginal ureterocele as a cause of urinary incontinence in a child.

Landi L, Elia A, Adorisio O.

Urol J. 2015 Feb 22;12(1):1999-2000. No abstract available.

48.

Nit-picking around second line in EGFRwt NSCLC: just an academic effort.

Landi L, Cappuzzo F.

Ann Oncol. 2015 Mar;26(3):448-50. doi: 10.1093/annonc/mdu575. Epub 2014 Dec 19. No abstract available.

PMID:
25527415
49.

PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients.

D'Incecco A, Andreozzi M, Ludovini V, Rossi E, Capodanno A, Landi L, Tibaldi C, Minuti G, Salvini J, Coppi E, Chella A, Fontanini G, Filice ME, Tornillo L, Incensati RM, Sani S, Crinò L, Terracciano L, Cappuzzo F.

Br J Cancer. 2015 Jan 6;112(1):95-102. doi: 10.1038/bjc.2014.555. Epub 2014 Oct 28.

50.

Management of NSCLC: focus on crizotinib.

Landi L, Cappuzzo F.

Expert Opin Pharmacother. 2014 Dec;15(17):2587-97. doi: 10.1517/14656566.2014.970174. Epub 2014 Oct 10. Review.

PMID:
25301075

Supplemental Content

Support Center